By Justin Petrone
Oxford Gene Technology will use its protein and microRNA-profiling microarray platforms as part of a project with Abcodia to develop tests for the early detection of pancreatic cancer, the firms announced this week.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.
Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.
FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.
Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.